NANOBIOTIX Announces Pricing Of A Capital Increase Raising Total Gross Proceeds Of $55M An Offering Of 3,106,907 American Depositary Shares At An Offering Price Of $5.36 Per ADS
Portfolio Pulse from Benzinga Newsdesk
Nanobiotix has announced the pricing of its global follow-on offering, raising total gross proceeds of $55M. The offering consists of 3,106,907 American Depositary Shares (ADSs) at an offering price of $5.36 per ADS. Johnson & Johnson Innovation – JJDC, Inc. is obligated to subscribe for $25.0 million of Ordinary Shares in the form of restricted ADSs. The aggregate gross proceeds of the Global Offering and the Concurrent Private Placement are expected to be approximately $55 million. Jefferies LLC, Leerink Partners and Guggenheim are acting as global coordinators and joint bookrunners for the Global Offering.
November 02, 2023 | 2:53 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Nanobiotix is raising $55M through a global follow-on offering. Johnson & Johnson Innovation is obligated to subscribe for $25M of Ordinary Shares. This could potentially dilute the value of existing shares.
The announcement of a follow-on offering could potentially dilute the value of existing shares, which may lead to a short-term negative impact on the stock price. However, the involvement of Johnson & Johnson Innovation could be seen as a positive endorsement of the company's prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100